Percutaneous Transhepatic Gallbladder Stenting for Acute Cholecystitis after Palliative Metallic Biliary Stenting.
- Author:
Hwal Suk CHO
1
;
Sun Mi LEE
;
Chan Won PARK
;
Ji Young KIM
;
Do Hoon KIM
;
Kee Tae PARK
;
Tae Oh KIM
;
Jeong HEO
;
Gwang Ha KIM
;
Dae Hwan KANG
;
Geun Am SONG
;
Mong CHO
Author Information
1. Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea. hero0791@paran.com
- Publication Type:Case Report
- Keywords:
Percutaneous transhepatic gallbladder stenting;
Acute cholecystitis
- MeSH:
Cholecystitis, Acute*;
Cholecystostomy;
Cystic Duct;
Gallbladder*;
Humans;
Life Expectancy;
Quality of Life;
Stents*
- From:Korean Journal of Gastrointestinal Endoscopy
2006;33(5):322-325
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Metallic biliary stenting to relieve a malignant biliary obstruction can cause a cystic duct obstruction and acute cholecystitis. Percutaneous transhepatic cholecystostomy is often performed in patients with a limited life expectancy but can have a significant impact on the quality of life. Percutaneous transhepatic gallbladder stenting (PTGS) was performed across the cystic duct via the cholecystostomy tube tract to allow the removal of the cholecystostomy tube. The patient remained asymptomatic for 7 months after PTGS. In conclusion, PTGS across the cystic duct may be considered a treatment option in selected patients who develop acute cholecystitis after palliative metallic biliary stenting.
